FOI 26-2682 – NDSS Supply Limits Of Diabetes Products

Written by Claude Haiku 4.5 from the extracted text on 16 May 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The National Diabetes Services Scheme (NDSS) applies annual supply limits to continuous glucose monitoring (CGM) devices based on manufacturer recommendations, with base allocations ranging from 420-480 days and extended allocations providing 504-570 days of supply. Covered devices include FreeStyle Libre 2/2&3 Plus (30-36 sensors annually), Dexcom G6/G7 (16-45 sensors plus transmitters), and Medtronic Guardian 4 (13-15 sensor packs plus transmitters). Individual extensions of three months' supply may be granted once yearly for product loss, misunderstanding of lifespan, or travel. Non-CGM diabetes products (blood glucose test strips, sharps, infusion sets) lack fixed annual limits but operate under suggested maximum usage thresholds: 900 test strips per 180 days, 1200 pen needles/syringes per 180 days, and 90 infusion sets/reservoirs per 180 days. NDSS Connect transaction limits restrict single orders to 3 boxes for test strips or urine strips, and 3-month CGM supplies. Users exceeding suggested thresholds are directed to contact the NDSS Helpline.